Skip to content

Rapid Micro Biosystems RPID Free cash flow yield

Free cash flow yield at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
4.6%-2.7pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
4.7%-0.5pp
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
-29.2%-8.7pp
iRadimed logo
iRadimedIRMD
2%-0.2pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-44.3%-16.2pp
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
2.5%+0.6pp

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Calculated from Rapid Micro Biosystems’s reported figures.

Based on trailing twelve months.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's free cash flow yield?
Rapid Micro Biosystems (RPID) reported free cash flow yield of -36.8% in Q1 2026.
How has Rapid Micro Biosystems's free cash flow yield changed year-over-year?
Rapid Micro Biosystems's free cash flow yield decreased by 8.3% year-over-year, from -34% to -36.8%.
What is the long-term trend for Rapid Micro Biosystems's free cash flow yield?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's free cash flow yield has grown at a 17.1% compound annual growth rate (CAGR), from -13.2% to -24.8%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.